Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PerioChip in Peri-Implantitis
NCT02080403Phase 3Completed
- Sponsor
- Dexcel Pharma
- Start
- Jul 2014
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of chlorhexidine in peri-implantitis, sponsored by Dexcel Pharma. Started Jul 2014; status: completed.
02
Drugs
chlorhexidine
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on NCT02080403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02080403.